Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblasts play a crucial role in the body's response to implants, needing more research for better treatments.

These hair loss conditions might be part of a spectrum, not separate issues.

Myofibroblasts in rat wound healing may come from blood vessel pericytes and perifollicular dermal sheath cells.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

The document covers books on cosmetic surgery and skin care, discussing legal and ethical issues, wound healing, the overlap of cosmetics and drugs, and detailed plastic surgery techniques.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Fibroblast state switching is crucial for skin healing and development.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

EF and PXE not closely related.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Mimicking fetal wound environments may enable scarless healing in adults.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Fibroblast transplantation improves wound healing, with dermal equivalents slightly enhancing skin regeneration.

Fetal skin can heal without scarring, offering insights for new scar-reducing treatments.

Fetal skin can heal without scars, offering insights for better wound treatments.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.